Position #2: The siRNA Approach with Inclisiran Will Take Over – Pierfranco Terrosu
21 Marzo 2024Colchicine and Beyond: emerging targets in inflammation in patients to acute and chronic coronary syndrome use – Massimo Imazio
25 Marzo 2024Position #2: The siRNA Approach with Inclisiran Will Take Over – Pierfranco Terrosu
21 Marzo 2024Colchicine and Beyond: emerging targets in inflammation in patients to acute and chronic coronary syndrome use – Massimo Imazio
25 Marzo 2024